• Expert opinion

    Watch these short videos from Professors Christian Domingo and Klaus Rabe about the burden of asthma, current unmet needs and their hopes for future care.

  • Focus on moderate, severe and uncontrolled asthma

    Understand the difference between moderate and severe asthma, and how to tell if a patient’s asthma is uncontrolled.

  • Key mediators in asthma inflammation

    Read about the underlying biological processes in the asthma inflammatory cascade and explore the potential therapeutic targets.

  • Overcoming the asthma treatment gap

    Why are patients still living with uncontrolled asthma where they can experience debilitating symptoms and are at risk of a severe attack despite current treatment options? What should be addressed in order to gain control? Find the answers, together with insightful footage from ERS expert interviews and key symposium in new content - coming soon. 

  • Effective asthma management

    Increase your awareness of the 2019 GINA report asthma management recommendations. Coming soon - additional information to help you efficiently utilise diagnostic tools and discover the importance of patient-reported outcomes.

 

Welcome to the Moderate to Severe Asthma Learning Zone

For many patients, asthma remains uncontrolled despite current therapy. This is the asthma treatment gap, which is still a big unmet need for these patients. It is estimated that 38% of patients are considered to be GINA Step 3 of the Global Initiative for Asthma (GINA) stepwise approach to asthma treatment, and 41% of patients are considered to be at Step 4 or 5 [Adelphi Disease Specific Programme (DSP) 2018]. Despite the availability of standard-of-care asthma treatments, 35% of GINA 3 patients and over 50% of patients at GINA Step 4 and 5, respectively, remain uncontrolled (i.e. symptomatic and experience exacerbations). To help overcome this and optimise your asthma management find out about the key inflammatory mediators involved, the therapeutic targets and information from the latest Global Initiative for Asthma (GINA), global strategy for asthma management and prevention report 2019,  (which should be used in conjunction with other local/national guideline recommendations).

Pathophysiology

Pathophysiology

Refresh your understanding of asthma pathophysiology and the inflammatory cascade by discovering more about potential therapeutic targets.

Asthma overview

Asthma overview

An updated overview to refresh your knowledge and understanding of asthma.

Asthma management

Asthma management

Learn about the stepwise approach to optimise control of moderate and severe asthma.

ERS International Congress 2019

ERS International Congress 2019

The epgonline.org team will be attending and reporting back from ERS 2019, held in Madrid, Spain between 28 September and 2 October providing daily blogs covering the most exciting developments in asthma and respiratory medicine.

This learning zone helps you further your knowledge around moderate and severe asthma and its management. It has been designed to support you in identifying effective approaches to optimise your management strategies, while also updating you about asthma and its treatment landscape.

Login/ Register Maximise Minimise